Merck KGaA Expects Organic Sales, Earnings Growth This Year
By Dominic Chopping
Germany's Merck KGaA expects to gradually return to organic growth this year after reporting a slump in earnings during 2023, which it called a "transitional" year.
The life-sciences and electronics company said profit after tax last year fell to 2.83 billion euros ($3.09 billion) from EUR3.34 billion in 2022 as sales slipped 5.6% to EUR20.99 billion.
Earnings before interest, taxes, depreciation and amortization before one-time items--the company's preferred profitability metric--fell 14% to EUR5.88 billion.
Analysts expected 2023 pre-items Ebitda at EUR5.86 billion on net sales of EUR20.97 billion, according to consensus estimates provided by the company.
Merck said the 2023 sales and earnings performance of the life science business sector was hurt by sharply lower Covid-19-related sales while the process solutions business slowed due to inventory destocking.
In electronics, earnings were weighed by the continuing cyclical slowdown in the semiconductor industry, but healthcare earnings rose.
"We delivered solid results in a transitional year 2023," said Chief Executive Belen Garijo. "Now, we are fully focusing on gradually returning to growth during fiscal 2024."
The company expects slight to moderate organic sales and pre-items Ebitda growth in 2024.
The company proposed an unchanged dividend for 2023 of EUR2.20 a share.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
March 07, 2024 01:45 ET (06:45 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks